IL1B and chronic obstructive pulmonary disease: The study also evaluated whether TNF-α or IL-1β could be prognostic markers and evaluated whether increasing severity of COPD is associated with increasing levels of these novel biomarkers, which could be a useful adjunct to spirometry or in subjects unable to perform spirometry, this could be a useful surrogate.